期刊文献+

胃黏膜保护剂在临床中的应用 被引量:7

下载PDF
导出
摘要 胃炎、胃溃疡等胃黏膜病变的发生是攻击因子(包括胃酸、胃蛋白酶、动力异常、胆酸、某些药物、酒精、以及幽门螺杆菌等)与防御因子(包括黏液黏膜屏障、黏膜血流、前列腺素、碳酸氢盐分泌及上皮再生)之间失衡所致。当前临床上对这类疾病的处理注意力多放在减少损伤因素方面,例如:使用H2受体拮抗剂或PPI抑制胃酸的分泌,对幽门螺杆菌阳性的患者给予根除治疗等。临床上对增加保护因素重视不够。使用黏膜保护剂,增加保护因素是治疗胃黏膜病变的重要方面。
作者 杨桂彬
出处 《中国医药导刊》 2008年第2期171-174,共4页 Chinese Journal of Medicinal Guide
  • 相关文献

参考文献17

  • 1胡伏莲.重视胃肠黏膜屏障的研究[J].中华医学杂志,2005,85(39):2737-2738. 被引量:14
  • 2Tarnawski A, Douglass TG, Stachura J, et al. Quality of gastric ulcer healing: histological and ultrastructural assessment. Aliment Pharmacol Ther, 1991 ;5 (1) :79 -90.
  • 3Kimura K, Yoshida Y, Kihira K, et al. Endoscopic ultrasonographic (EUS) evaluation of the quality of gastric ulcer healing. Gastroenterol Jpn, 1993 ;28 (5) : 178 - 185.
  • 4姒健敏,吴加国,曹倩.胃溃疡愈合质量初探[J].中华消化杂志,2003,23(6):374-376. 被引量:34
  • 5Shiu Kum Lam. Differences in peptic ulcer between East and West. Bailliere's Clinical Gastroenterology,2000 ; 14 ( 1 ) :41 - 52.
  • 6Watanabe K, Murakami K, Sato R, et al. Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. Antimicrob Agents Chemother, 2004 ;48 (12) :4582 -4588.
  • 7Lee SP. The mode of action of colloidal bismuth subcitrate. Scand J Gastroenterol, 1991 ; 185(Suppl) : 1 -6.
  • 8金哲,胡伏莲,杨桂彬.枸橼酸铋钾对预防乙醇所致大鼠急性胃粘膜损伤的实验研究[J].中国新药杂志,2001,10(8):587-590. 被引量:5
  • 9杨桂彬,胡伏莲,金哲.胶体枸橼酸铋钾预防阿司匹林所致大鼠胃粘膜损伤的研究[J].中国新药杂志,2002,11(6):452-454. 被引量:5
  • 10Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N Engl J Med, 1992;327(22) :1575 - 1580.

二级参考文献52

  • 1吕宾,张璐,范一宏,孟立娜,张烁.替普瑞酮对类固醇致胃黏膜损伤的保护作用[J].中华医学杂志,2005,85(39):2749-2753. 被引量:13
  • 2闫赞华,胡伏莲.米索前列醇和胶体次枸橼酸铋治疗幽门螺杆菌相关性慢性胃炎[J].中国新药杂志,1996,5(1):4-7. 被引量:4
  • 3胡伏莲,贾博琦,陈寿坡,林三仁,董秀芸,戴希真,张希全.替普瑞酮对胃溃疡愈合及其愈合质量的影响[J].中华内科杂志,1996,35(12):807-809. 被引量:26
  • 4陈宝雯 林兆鑫 等.表皮生长因子对胃粘膜保护作用的机理探讨[J].中华医学杂志,1994,74(6):351-351.
  • 5Okai T, Sawabu N, Songur Y,et al. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial. J Clin Gastroenterol, 1995,20 (suppl 2) :S32-35.
  • 6Tanaka M, Maruoka A, Chijiiwa Y, et al. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment-with proton pump inhibitors versus H2-receptor antagonists. Scand J Gastroentenol, 1994,29 : 1140-1144.
  • 7Si jianmin, Jin yiyi, Wu jiaguo, et al. The relationship between ulcer recurrence and helicobacter pylori : a prospective one-year followup study in china. Journal of Zhejiang University SCIENCE, 2000,1:227-228.
  • 8Tarnawski A, Stachura J, Willian JK, et al. Quality of gastric ulcer healing: a new, emerging concept. J Clin Gastroenterol, 1991,13(suppl 1) :S42-47.
  • 9Nishimaki T. Pathomorphological study on the healing process of chronic gastric ulcer. Morphological changes of fibrosis according to the progress of healing (in Japanese). Niigata Med J, 1983, 97:358-376.
  • 10Si JM, Jin YY, Wu JG, et al. The relationship between ulcer recurrence and Helicobacter pylori: a prospective one-year followup study in China. J Zhejiang University(SCIENCE), 2000, 1:226-228.

共引文献164

同被引文献48

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部